• Honored with the 2006 AZ Commercial Excellence Award for breakthrough insights launching the Pulmicort Respules® integrated HCP-consumer campaign which boosted sales 25% to $1.1 Billion.• Optimized digital consumer relationship communications with finely honed messages based on a needs-based segmentation with an 85% predictive power. The program sparked new business generating $100 Million. • Led Iressa® (Non-Small Cell Lung Cancer) launch optimization research, and performance tracking research. The learning was a blueprint for re-launching Iressa® in the ex-US with sparse commercial resources. • Led insights crafting the communication strategy and launch planning forecast assumptions for Brilinta® (Acute Coronary Syndrome), dapagliflozin (Type 2 Diabetes), and Caprelsa® (Medullary Thyroid Cancer).